New Diarylamine KV10.1 Inhibitors and Their Anticancer Potential
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14091963
Abstract: Expression of the voltage-gated potassium channel KV10.1 (Eag1) has been detected in over 70% of human cancers, making the channel a promising new target for new anticancer drug discovery. A new structural class of KV10.1… read more here.
Keywords: 17a 18b; diarylamine kv10; kv10 inhibitors; new diarylamine ... See more keywords